Literature DB >> 32284960

Extensive memory testing improves prediction of progression to MCI in late middle age.

Daniel E Gustavson1,2, Jeremy A Elman2, Mark Sanderson-Cimino2, Carol E Franz2, Matthew S Panizzon2, Amy J Jak2,3, Chandra A Reynolds4, Michael C Neale5, Michael J Lyons6, William S Kremen2,3.   

Abstract

INTRODUCTION: Predicting risk for Alzheimer's disease when most people are likely still biomarker negative would aid earlier identification. We hypothesized that combining multiple memory tests and scores in middle-aged adults would provide useful, and non-invasive, prediction of 6-year progression to MCI.
METHODS: We examined 849 men who were cognitively normal at baseline (mean age ± SD = 55.69 ± 2.45).
RESULTS: California Verbal Learning Test learning trials was the best individual predictor of amnestic MCI (OR = 4.75). A latent factor incorporating seven measures across three memory tests provided much stronger prediction (OR = 9.88). This compared favorably with biomarker-based prediction in a study of much older adults. DISCUSSION: Neuropsychological tests are sensitive and early indicators of MCI risk at an age when few individuals are likely to have yet become biomarker positive. The single best measures may appear time- and cost-effective, but 30 additional minutes of testing and use of multiple scores within tests provide substantially improved prediction.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; mild cognitive impairment; neuropsychology

Year:  2020        PMID: 32284960      PMCID: PMC7148418          DOI: 10.1002/dad2.12004

Source DB:  PubMed          Journal:  Alzheimers Dement (Amst)        ISSN: 2352-8729


  42 in total

1.  Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.

Authors:  Andrea R Zammit; Graciela Muniz-Terrera; Mindy J Katz; Charles B Hall; Ali Ezzati; David A Bennett; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.

Authors:  Todd E Golde; Lon S Schneider; Edward H Koo
Journal:  Neuron       Date:  2011-01-27       Impact factor: 17.173

3.  Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.

Authors:  Guoqiao Wang; Dean Coble; Eric M McDade; Jason Hassenstab; Anne M Fagan; Tammie L S Benzinger; Randall J Bateman; John C Morris; Chengjie Xiong
Journal:  Alzheimers Dement       Date:  2019-02-15       Impact factor: 21.566

4.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

5.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

6.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Genetic complexity of episodic memory: a twin approach to studies of aging.

Authors:  William S Kremen; Matthew S Panizzon; Carol E Franz; Kelly M Spoon; Eero Vuoksimaa; Kristen C Jacobson; Terrie Vasilopoulos; Hong Xian; Jeanne M McCaffery; Brinda K Rana; Rosemary Toomey; Ruth McKenzie; Michael J Lyons
Journal:  Psychol Aging       Date:  2014-06

8.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Authors:  Willemijn J Jansen; Rik Ossenkoppele; Dirk L Knol; Betty M Tijms; Philip Scheltens; Frans R J Verhey; Pieter Jelle Visser; Pauline Aalten; Dag Aarsland; Daniel Alcolea; Myriam Alexander; Ina S Almdahl; Steven E Arnold; Inês Baldeiras; Henryk Barthel; Bart N M van Berckel; Kristen Bibeau; Kaj Blennow; David J Brooks; Mark A van Buchem; Vincent Camus; Enrica Cavedo; Kewei Chen; Gael Chetelat; Ann D Cohen; Alexander Drzezga; Sebastiaan Engelborghs; Anne M Fagan; Tormod Fladby; Adam S Fleisher; Wiesje M van der Flier; Lisa Ford; Stefan Förster; Juan Fortea; Nadia Foskett; Kristian S Frederiksen; Yvonne Freund-Levi; Giovanni B Frisoni; Lutz Froelich; Tomasz Gabryelewicz; Kiran Dip Gill; Olymbia Gkatzima; Estrella Gómez-Tortosa; Mark Forrest Gordon; Timo Grimmer; Harald Hampel; Lucrezia Hausner; Sabine Hellwig; Sanna-Kaisa Herukka; Helmut Hildebrandt; Lianna Ishihara; Adrian Ivanoiu; William J Jagust; Peter Johannsen; Ramesh Kandimalla; Elisabeth Kapaki; Aleksandra Klimkowicz-Mrowiec; William E Klunk; Sebastian Köhler; Norman Koglin; Johannes Kornhuber; Milica G Kramberger; Koen Van Laere; Susan M Landau; Dong Young Lee; Mony de Leon; Viviana Lisetti; Alberto Lleó; Karine Madsen; Wolfgang Maier; Jan Marcusson; Niklas Mattsson; Alexandre de Mendonça; Olga Meulenbroek; Philipp T Meyer; Mark A Mintun; Vincent Mok; José Luis Molinuevo; Hanne M Møllergård; John C Morris; Barbara Mroczko; Stefan Van der Mussele; Duk L Na; Andrew Newberg; Agneta Nordberg; Arto Nordlund; Gerald P Novak; George P Paraskevas; Lucilla Parnetti; Gayan Perera; Oliver Peters; Julius Popp; Sudesh Prabhakar; Gil D Rabinovici; Inez H G B Ramakers; Lorena Rami; Catarina Resende de Oliveira; Juha O Rinne; Karen M Rodrigue; Eloy Rodríguez-Rodríguez; Catherine M Roe; Uros Rot; Christopher C Rowe; Eckart Rüther; Osama Sabri; Páscual Sanchez-Juan; Isabel Santana; Marie Sarazin; Johannes Schröder; Christin Schütte; Sang W Seo; Femke Soetewey; Hilkka Soininen; Luiza Spiru; Hanne Struyfs; Charlotte E Teunissen; Magda Tsolaki; Rik Vandenberghe; Marcel M Verbeek; Victor L Villemagne; Stephanie J B Vos; Linda J C van Waalwijk van Doorn; Gunhild Waldemar; Anders Wallin; Åsa K Wallin; Jens Wiltfang; David A Wolk; Marzena Zboch; Henrik Zetterberg
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

9.  Hippocampal atrophy varies by neuropsychologically defined MCI among men in their 50s.

Authors:  Amy J Jak; Matthew S Panizzon; Kelly M Spoon; Christine Fennema-Notestine; Carol E Franz; Wesley K Thompson; Kristen C Jacobson; Hong Xian; Lisa T Eyler; Eero Vuoksimaa; Rosemary Toomey; Michael J Lyons; Michael C Neale; Ming T Tsuang; Anders M Dale; William S Kremen
Journal:  Am J Geriatr Psychiatry       Date:  2014-08-29       Impact factor: 4.105

10.  Underdiagnosis of mild cognitive impairment: A consequence of ignoring practice effects.

Authors:  Jeremy A Elman; Amy J Jak; Matthew S Panizzon; Xin M Tu; Tian Chen; Chandra A Reynolds; Daniel E Gustavson; Carol E Franz; Sean N Hatton; Kristen C Jacobson; Rosemary Toomey; Ruth McKenzie; Hong Xian; Michael J Lyons; William S Kremen
Journal:  Alzheimers Dement (Amst)       Date:  2018-05-14
View more
  9 in total

1.  Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.

Authors:  Jeremy A Elman; Eero Vuoksimaa; Carol E Franz; William S Kremen
Journal:  Neurobiol Aging       Date:  2020-06-11       Impact factor: 4.673

2.  Alzheimer's Disease Polygenic Scores Predict Changes in Episodic Memory and Executive Function Across 12 Years in Late Middle Age.

Authors:  Daniel E Gustavson; Chandra A Reynolds; Timothy J Hohman; Angela L Jefferson; Jeremy A Elman; Matthew S Panizzon; Michael C Neale; Mark W Logue; Michael J Lyons; Carol E Franz; William S Kremen
Journal:  J Int Neuropsychol Soc       Date:  2022-02-21       Impact factor: 3.114

3.  Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Daniel E Gustavson; Carol E Franz; Mark E Sanderson-Cimino; Michael J Lyons; William S Kremen
Journal:  Biol Psychiatry       Date:  2020-01-07       Impact factor: 13.382

4.  How Well Does Subjective Cognitive Decline Correspond to Objectively Measured Cognitive Decline? Assessment of 10-12 Year Change.

Authors:  Daniel E Gustavson; Amy J Jak; Jeremy A Elman; Matthew S Panizzon; Carol E Franz; Katherine A Gifford; Chandra A Reynolds; Rosemary Toomey; Michael J Lyons; William S Kremen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  MRI-assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction.

Authors:  Jeremy A Elman; Olivia K Puckett; Asad Beck; Christine Fennema-Notestine; Latonya K Cross; Anders M Dale; Graham M L Eglit; Lisa T Eyler; Nathan A Gillespie; Eric L Granholm; Daniel E Gustavson; Donald J Hagler; Sean N Hatton; Richard Hauger; Amy J Jak; Mark W Logue; Linda K McEvoy; Ruth E McKenzie; Michael C Neale; Matthew S Panizzon; Chandra A Reynolds; Mark Sanderson-Cimino; Rosemary Toomey; Xin M Tu; Nathan Whitsel; McKenna E Williams; Hong Xian; Michael J Lyons; Carol E Franz; William S Kremen
Journal:  Alzheimers Dement       Date:  2021-02-13       Impact factor: 21.566

6.  Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials.

Authors:  Mark Sanderson-Cimino; Jeremy A Elman; Xin M Tu; Alden L Gross; Matthew S Panizzon; Daniel E Gustavson; Mark W Bondi; Emily C Edmonds; Graham M L Eglit; Joel S Eppig; Carol E Franz; Amy J Jak; Michael J Lyons; Kelsey R Thomas; McKenna E Williams; William S Kremen
Journal:  Alzheimers Dement (N Y)       Date:  2022-02-01

7.  Memory markers in the continuum of the Alzheimer's clinical syndrome.

Authors:  Mario A Parra; Clara Calia; Vivek Pattan; Sergio Della Sala
Journal:  Alzheimers Res Ther       Date:  2022-09-30       Impact factor: 8.823

8.  Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals.

Authors:  Xue-Ning Shen; Kevin Kuo; Yu-Xiang Yang; Hong-Qi Li; Shi-Dong Chen; Mei Cui; Lan Tan; Qiang Dong; Jin-Tai Yu
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-27

9.  Cognitive Practice Effects Delay Diagnosis; Implications for Clinical Trials.

Authors:  Mark Sanderson-Cimino; Jeremy A Elman; Xin M Tu; Alden L Gross; Matthew S Panizzon; Daniel E Gustavson; Mark W Bondi; Emily C Edmonds; Graham M L Eglit; Joel S Eppig; Carol E Franz; Amy J Jak; Michael J Lyons; Kelsey R Thomas; McKenna E Williams; William S Kremen
Journal:  medRxiv       Date:  2020-11-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.